Global Infectious Respiratory Disease Diagnostics Market Growth (Status and Outlook) 2022-2028

Publication Month: Dec 2022 | No. of Pages: 102 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

The global market for Infectious Respiratory Disease Diagnostics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Infectious Respiratory Disease Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Infectious Respiratory Disease Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Infectious Respiratory Disease Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Infectious Respiratory Disease Diagnostics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Infectious Respiratory Disease Diagnostics players cover Abbott, Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd. and BioMerieux SA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Infectious Respiratory Disease Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Infectious Respiratory Disease Diagnostics market, with both quantitative and qualitative data, to help readers understand how the Infectious Respiratory Disease Diagnostics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Infectious Respiratory Disease Diagnostics market and forecasts the market size by Type (Instruments, Consumables and Services), by Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV) and Tuberculosis), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Instruments
Consumables
Services
Segmentation by application
COVID-19
Influenza
Respiratory Syncytial Virus (RSV)
Tuberculosis
Streptococcus Testing
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott
Thermo Fisher Scientific, Inc.
Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
BioMerieux SA
Bio-Rad Laboratories, Inc.
Quidel Corporation
Siemens Healthcare GmbH
Danaher
Qiagen
Chapter Introduction
Chapter 1: Scope of Infectious Respiratory Disease Diagnostics, Research Methodology, etc.
Chapter 2: Executive Summary, global Infectious Respiratory Disease Diagnostics market size and CAGR, Infectious Respiratory Disease Diagnostics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Infectious Respiratory Disease Diagnostics revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Infectious Respiratory Disease Diagnostics revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Infectious Respiratory Disease Diagnostics market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Abbott, Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., BioMerieux SA, Bio-Rad Laboratories, Inc., Quidel Corporation, Siemens Healthcare GmbH and Danaher, etc.
Chapter 14: Research Findings and Conclusion

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Respiratory Disease Diagnostics Market Size 2017-2028
2.1.2 Infectious Respiratory Disease Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Infectious Respiratory Disease Diagnostics Segment by Type
2.2.1 Instruments
2.2.2 Consumables
2.2.3 Services
2.3 Infectious Respiratory Disease Diagnostics Market Size by Type
2.3.1 Infectious Respiratory Disease Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Infectious Respiratory Disease Diagnostics Segment by Application
2.4.1 COVID-19
2.4.2 Influenza
2.4.3 Respiratory Syncytial Virus (RSV)
2.4.4 Tuberculosis
2.4.5 Streptococcus Testing
2.5 Infectious Respiratory Disease Diagnostics Market Size by Application
2.5.1 Infectious Respiratory Disease Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Application (2017-2022)
3 Infectious Respiratory Disease Diagnostics Market Size by Player
3.1 Infectious Respiratory Disease Diagnostics Market Size Market Share by Players
3.1.1 Global Infectious Respiratory Disease Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Infectious Respiratory Disease Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Respiratory Disease Diagnostics by Regions
4.1 Infectious Respiratory Disease Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Infectious Respiratory Disease Diagnostics Market Size Growth (2017-2022)
4.3 APAC Infectious Respiratory Disease Diagnostics Market Size Growth (2017-2022)
4.4 Europe Infectious Respiratory Disease Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Infectious Respiratory Disease Diagnostics Market Size by Country (2017-2022)
5.2 Americas Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022)
5.3 Americas Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Respiratory Disease Diagnostics Market Size by Region (2017-2022)
6.2 APAC Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022)
6.3 APAC Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Respiratory Disease Diagnostics by Country (2017-2022)
7.2 Europe Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022)
7.3 Europe Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Respiratory Disease Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Infectious Respiratory Disease Diagnostics Market Forecast
10.1 Global Infectious Respiratory Disease Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Infectious Respiratory Disease Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Infectious Respiratory Disease Diagnostics Forecast
10.1.3 APAC Infectious Respiratory Disease Diagnostics Forecast
10.1.4 Europe Infectious Respiratory Disease Diagnostics Forecast
10.1.5 Middle East & Africa Infectious Respiratory Disease Diagnostics Forecast
10.2 Americas Infectious Respiratory Disease Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Infectious Respiratory Disease Diagnostics Market Forecast
10.2.2 Canada Infectious Respiratory Disease Diagnostics Market Forecast
10.2.3 Mexico Infectious Respiratory Disease Diagnostics Market Forecast
10.2.4 Brazil Infectious Respiratory Disease Diagnostics Market Forecast
10.3 APAC Infectious Respiratory Disease Diagnostics Forecast by Region (2023-2028)
10.3.1 China Infectious Respiratory Disease Diagnostics Market Forecast
10.3.2 Japan Infectious Respiratory Disease Diagnostics Market Forecast
10.3.3 Korea Infectious Respiratory Disease Diagnostics Market Forecast
10.3.4 Southeast Asia Infectious Respiratory Disease Diagnostics Market Forecast
10.3.5 India Infectious Respiratory Disease Diagnostics Market Forecast
10.3.6 Australia Infectious Respiratory Disease Diagnostics Market Forecast
10.4 Europe Infectious Respiratory Disease Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Infectious Respiratory Disease Diagnostics Market Forecast
10.4.2 France Infectious Respiratory Disease Diagnostics Market Forecast
10.4.3 UK Infectious Respiratory Disease Diagnostics Market Forecast
10.4.4 Italy Infectious Respiratory Disease Diagnostics Market Forecast
10.4.5 Russia Infectious Respiratory Disease Diagnostics Market Forecast
10.5 Middle East & Africa Infectious Respiratory Disease Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Infectious Respiratory Disease Diagnostics Market Forecast
10.5.2 South Africa Infectious Respiratory Disease Diagnostics Market Forecast
10.5.3 Israel Infectious Respiratory Disease Diagnostics Market Forecast
10.5.4 Turkey Infectious Respiratory Disease Diagnostics Market Forecast
10.5.5 GCC Countries Infectious Respiratory Disease Diagnostics Market Forecast
10.6 Global Infectious Respiratory Disease Diagnostics Forecast by Type (2023-2028)
10.7 Global Infectious Respiratory Disease Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Infectious Respiratory Disease Diagnostics Product Offered
11.1.3 Abbott Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Information
11.2.2 Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific, Inc. Latest Developments
11.3 Koninklijke Philips N.V.
11.3.1 Koninklijke Philips N.V. Company Information
11.3.2 Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Product Offered
11.3.3 Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Koninklijke Philips N.V. Main Business Overview
11.3.5 Koninklijke Philips N.V. Latest Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Information
11.4.2 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Product Offered
11.4.3 F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.4.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.5 BioMerieux SA
11.5.1 BioMerieux SA Company Information
11.5.2 BioMerieux SA Infectious Respiratory Disease Diagnostics Product Offered
11.5.3 BioMerieux SA Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 BioMerieux SA Main Business Overview
11.5.5 BioMerieux SA Latest Developments
11.6 Bio-Rad Laboratories, Inc.
11.6.1 Bio-Rad Laboratories, Inc. Company Information
11.6.2 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Product Offered
11.6.3 Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bio-Rad Laboratories, Inc. Main Business Overview
11.6.5 Bio-Rad Laboratories, Inc. Latest Developments
11.7 Quidel Corporation
11.7.1 Quidel Corporation Company Information
11.7.2 Quidel Corporation Infectious Respiratory Disease Diagnostics Product Offered
11.7.3 Quidel Corporation Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Quidel Corporation Main Business Overview
11.7.5 Quidel Corporation Latest Developments
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Information
11.8.2 Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Product Offered
11.8.3 Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Siemens Healthcare GmbH Main Business Overview
11.8.5 Siemens Healthcare GmbH Latest Developments
11.9 Danaher
11.9.1 Danaher Company Information
11.9.2 Danaher Infectious Respiratory Disease Diagnostics Product Offered
11.9.3 Danaher Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Danaher Main Business Overview
11.9.5 Danaher Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Infectious Respiratory Disease Diagnostics Product Offered
11.10.3 Qiagen Infectious Respiratory Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Infectious Respiratory Disease Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Instruments
Table 3. Major Players of Consumables
Table 4. Major Players of Services
Table 5. Infectious Respiratory Disease Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Type (2017-2022)
Table 8. Infectious Respiratory Disease Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Application (2017-2022)
Table 11. Global Infectious Respiratory Disease Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Player (2020-2022)
Table 13. Infectious Respiratory Disease Diagnostics Key Players Head office and Products Offered
Table 14. Infectious Respiratory Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Infectious Respiratory Disease Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Infectious Respiratory Disease Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Infectious Respiratory Disease Diagnostics Market Size Market Share by Country (2017-2022)
Table 21. Americas Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Infectious Respiratory Disease Diagnostics Market Size Market Share by Type (2017-2022)
Table 23. Americas Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Infectious Respiratory Disease Diagnostics Market Size Market Share by Application (2017-2022)
Table 25. APAC Infectious Respiratory Disease Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Infectious Respiratory Disease Diagnostics Market Size Market Share by Region (2017-2022)
Table 27. APAC Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Infectious Respiratory Disease Diagnostics Market Size Market Share by Type (2017-2022)
Table 29. APAC Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Infectious Respiratory Disease Diagnostics Market Size Market Share by Application (2017-2022)
Table 31. Europe Infectious Respiratory Disease Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Infectious Respiratory Disease Diagnostics Market Size Market Share by Country (2017-2022)
Table 33. Europe Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Infectious Respiratory Disease Diagnostics Market Size Market Share by Type (2017-2022)
Table 35. Europe Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Infectious Respiratory Disease Diagnostics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Infectious Respiratory Disease Diagnostics
Table 44. Key Market Challenges & Risks of Infectious Respiratory Disease Diagnostics
Table 45. Key Industry Trends of Infectious Respiratory Disease Diagnostics
Table 46. Global Infectious Respiratory Disease Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Infectious Respiratory Disease Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Infectious Respiratory Disease Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Infectious Respiratory Disease Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Infectious Respiratory Disease Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Infectious Respiratory Disease Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Abbott Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 53. Abbott Infectious Respiratory Disease Diagnostics Product Offered
Table 54. Abbott Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Abbott Main Business
Table 56. Abbott Latest Developments
Table 57. Thermo Fisher Scientific, Inc. Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 58. Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Product Offered
Table 59. Thermo Fisher Scientific, Inc. Main Business
Table 60. Thermo Fisher Scientific, Inc. Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Thermo Fisher Scientific, Inc. Latest Developments
Table 62. Koninklijke Philips N.V. Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 63. Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Product Offered
Table 64. Koninklijke Philips N.V. Main Business
Table 65. Koninklijke Philips N.V. Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Koninklijke Philips N.V. Latest Developments
Table 67. F. Hoffmann-La Roche Ltd. Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 68. F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Product Offered
Table 69. F. Hoffmann-La Roche Ltd. Main Business
Table 70. F. Hoffmann-La Roche Ltd. Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. F. Hoffmann-La Roche Ltd. Latest Developments
Table 72. BioMerieux SA Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 73. BioMerieux SA Infectious Respiratory Disease Diagnostics Product Offered
Table 74. BioMerieux SA Main Business
Table 75. BioMerieux SA Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. BioMerieux SA Latest Developments
Table 77. Bio-Rad Laboratories, Inc. Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 78. Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Product Offered
Table 79. Bio-Rad Laboratories, Inc. Main Business
Table 80. Bio-Rad Laboratories, Inc. Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Bio-Rad Laboratories, Inc. Latest Developments
Table 82. Quidel Corporation Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 83. Quidel Corporation Infectious Respiratory Disease Diagnostics Product Offered
Table 84. Quidel Corporation Main Business
Table 85. Quidel Corporation Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Quidel Corporation Latest Developments
Table 87. Siemens Healthcare GmbH Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 88. Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Product Offered
Table 89. Siemens Healthcare GmbH Main Business
Table 90. Siemens Healthcare GmbH Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Siemens Healthcare GmbH Latest Developments
Table 92. Danaher Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 93. Danaher Infectious Respiratory Disease Diagnostics Product Offered
Table 94. Danaher Main Business
Table 95. Danaher Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Danaher Latest Developments
Table 97. Qiagen Details, Company Type, Infectious Respiratory Disease Diagnostics Area Served and Its Competitors
Table 98. Qiagen Infectious Respiratory Disease Diagnostics Product Offered
Table 99. Qiagen Main Business
Table 100. Qiagen Infectious Respiratory Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Qiagen Latest Developments
List of Figures
List of Figures
Figure 1. Infectious Respiratory Disease Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Respiratory Disease Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Type in 2021
Figure 7. Infectious Respiratory Disease Diagnostics in COVID-19
Figure 8. Global Infectious Respiratory Disease Diagnostics Market: COVID-19 (2017-2022) & ($ Millions)
Figure 9. Infectious Respiratory Disease Diagnostics in Influenza
Figure 10. Global Infectious Respiratory Disease Diagnostics Market: Influenza (2017-2022) & ($ Millions)
Figure 11. Infectious Respiratory Disease Diagnostics in Respiratory Syncytial Virus (RSV)
Figure 12. Global Infectious Respiratory Disease Diagnostics Market: Respiratory Syncytial Virus (RSV) (2017-2022) & ($ Millions)
Figure 13. Infectious Respiratory Disease Diagnostics in Tuberculosis
Figure 14. Global Infectious Respiratory Disease Diagnostics Market: Tuberculosis (2017-2022) & ($ Millions)
Figure 15. Infectious Respiratory Disease Diagnostics in Streptococcus Testing
Figure 16. Global Infectious Respiratory Disease Diagnostics Market: Streptococcus Testing (2017-2022) & ($ Millions)
Figure 17. Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Application in 2021
Figure 18. Global Infectious Respiratory Disease Diagnostics Revenue Market Share by Player in 2021
Figure 19. Global Infectious Respiratory Disease Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Infectious Respiratory Disease Diagnostics Market Size 2017-2022 ($ Millions)
Figure 21. APAC Infectious Respiratory Disease Diagnostics Market Size 2017-2022 ($ Millions)
Figure 22. Europe Infectious Respiratory Disease Diagnostics Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size 2017-2022 ($ Millions)
Figure 24. Americas Infectious Respiratory Disease Diagnostics Value Market Share by Country in 2021
Figure 25. Americas Infectious Respiratory Disease Diagnostics Consumption Market Share by Type in 2021
Figure 26. Americas Infectious Respiratory Disease Diagnostics Market Size Market Share by Application in 2021
Figure 27. United States Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Infectious Respiratory Disease Diagnostics Market Size Market Share by Region in 2021
Figure 32. APAC Infectious Respiratory Disease Diagnostics Market Size Market Share by Application in 2021
Figure 33. China Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Infectious Respiratory Disease Diagnostics Market Size Market Share by Country in 2021
Figure 40. Europe Infectious Respiratory Disease Diagnostics Market Size Market Share by Type in 2021
Figure 41. Europe Infectious Respiratory Disease Diagnostics Market Size Market Share by Application in 2021
Figure 42. Germany Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size Market Share by Application in 2021
Figure 50. Egypt Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Infectious Respiratory Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. APAC Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. Europe Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. United States Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Canada Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. China Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Japan Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. Korea Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. India Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. Australia Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. Germany Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. France Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. UK Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Italy Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Russia Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. Spain Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. Israel Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Infectious Respiratory Disease Diagnostics Market Size 2023-2028 ($ Millions)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets